MedTrace Logo

Optimal Regimen in Endovascular Therapy in Ischemic Cerebrovascular Disease Based on Clopidogrel Resistance

NCT01925872 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2015-01-28

No results posted yet for this study

Summary

1. Clopidogrel resistance is common in patients of ischemic cerebrovascular disease.
2. Genetic polymorphisms are the most important factors to clopidogrel resistance.
3. The purpose of this study is to find the genes which are the related to clopidogrel resistance.
4. Through gene sequencing, we can filter patient of clopidogrel resistance, so another drug maybe used to avoid the undesired efficacy.

Conditions

  • Ischemic Cerebrovascular Disease

Sponsors & Collaborators

  • Zhongrong Miao

    lead OTHER

Principal Investigators

  • Ning Ma, Doctor · Beijing Tiantan Hospital

Eligibility

Min Age
25 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2015-05-31
Completion
2015-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01925872 on ClinicalTrials.gov